Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors
- PMID: 1696165
Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors
Abstract
The effect of recombinant human tumor necrosis factor alpha (TNF-alpha) on normal and chronic myeloid leukemia granulocyte-macrophage progenitors (CFU-GM) growing in semisolid agar cultures in the presence of recombinant granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor was studied. Granulocyte-macrophage colony-stimulating factor-dependent growth of normal and chronic myeloid leukemia bone marrow CFU-GM was greatly enhanced by TNF-alpha at doses of 0.1 to 100 units/ml. Growth enhancement included neutrophil, eosinophil, and monocyte-macrophage colonies and clusters at 7 and 14 days of culture. Since similar results were achieved with highly enriched progenitor cell populations, devoid of accessory cells, an indirect effect on CFU-GM growth through the release by accessory cells of other cytokines upon TNF-alpha stimulation was thus ruled out. By contrast, the same doses of TNF-alpha inhibited the growth of normal CFU-GM in granulocyte colony-stimulating factor-dependent cultures. Taken together, our findings indicate that the final effect of TNF-alpha on normal bone marrow granulocyte-macrophage progenitor growth is dependent on the specific growth factor interacting with it, and that both normal and chronic myeloid leukemia CFU-GM are equally responsive to the combined effects of TNF-alpha and a given colony-stimulating factor.
Similar articles
-
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.Cancer Res. 1987 Sep 15;47(18):4788-94. Cancer Res. 1987. PMID: 3040231
-
Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.J Immunol. 1992 Oct 15;149(8):2681-8. J Immunol. 1992. PMID: 1383322
-
Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.Exp Hematol. 1989 Feb;17(2):191-7. Exp Hematol. 1989. PMID: 2463933
-
Hematopoietic growth factors: biology and clinical application.J Natl Cancer Inst Monogr. 1990;(10):73-7. J Natl Cancer Inst Monogr. 1990. PMID: 1693284 Review.
-
Lymphokines: enhancement by granulocyte-macrophage and granulocyte colony-stimulating factors of neonatal myeloid kinetics and functional activation of polymorphonuclear leukocytes.Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S492-7. doi: 10.1093/clinids/12.supplement_4.s492. Rev Infect Dis. 1990. PMID: 1694596 Review.
Cited by
-
Opposing effects of tumor necrosis factor alpha and leukemia inhibitory factor in lipopolysaccharide-stimulated myelopoiesis.Infect Immun. 1993 Feb;61(2):418-22. doi: 10.1128/iai.61.2.418-422.1993. Infect Immun. 1993. PMID: 7678584 Free PMC article.
-
Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha.Int J Hematol. 2008 Jul;88(1):64-72. doi: 10.1007/s12185-008-0098-z. Epub 2008 May 20. Int J Hematol. 2008. PMID: 18484240
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical